2012, Number 4
<< Back Next >>
Ann Hepatol 2012; 11 (4)
Prognostic markers in cirrhotic patients requiring intensive care: a comparative prospective study
Ölmez S, Gümürdülü Y, Tas A, Karakoc E, Kara B, Kidik A
Language: English
References: 22
Page: 513-518
PDF size: 91.86 Kb.
ABSTRACT
Introduction. The use of prognostic models for cirrhotic patients admitted to the medical intensive care
unit (ICU) is of great importance, since they provide an objective evaluation for a group of patients with
high mortality rates and high resource utilization.
Objective. To evaluate the validity and to compare the
prognostic predictive value of the CTP, MELD, SOFA and APACHE II scoring systems in cirrhotic patients admitted
to the ICU, the CTP and MELD models being exclusive for patients with liver disease.
Material and
methods. Commonly used predictors of mortality such as age, sex, CTP, MELD, APACHE II and SOFA were
evaluated, and their prognostic value was investigated.
Results. A total of 201 patients were included in
this study. Patients who survived had mean CTP score of 9.5 ± 2.4, MELD score 18.1 ± 7.1, APACHE II score
of 13.4 ± 4.8 and SOFA score of 4.2 ± 2.6, compared to respective scores of 11.4 ± 2.8, 28.0 ± 11.2, 24.6 ±
10.4 and 8.7 ± 4.0 in patients who died. The difference between groups was statistically significant for
each of one of the scoring systems (p ‹ 0.001).
Conclusion. In this study, SOFA was found to be the most
powerful predictor of prognosis for cirrhotic patients admitted to the ICU. This was followed by APACHE II,
MELD and CTP models, in descending order of strength (AUROC values of 0.847, 0.821, 0.790 and 0.724,
respectively).
REFERENCES
Cholongitas E, Senzolo M, Patch D, et al. Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics. Aliment Pharmacol Ther 2004; 24: 453-64.
Northup PG, Wanamaker RC, Lee VD, et al. Model for End- Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 2005; 242: 244-51.
Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg Aug 1973; 60: 646-9.
Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003; 52: 134-9.
Ho YP, Chen YC, Yang C, et al. Outcome prediction for critically ill cirrhotic patients: A comparison of APACHE II and Child-Pugh scoring systems. J Intensive Care Medicine 2004; 19: 105-10.
Wehler M, Kokoska J, Reulbach U, et al. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology 2001; 34: 255-61.
Chen YC, Tian YC, Liu NJ, et al. Prospective cohort study comparing sequential organ failure assessment and acute physiology, age, chronic health evaluation III scoring systems for hospital mortality prediction in critically ill cirrhotic patients. J Clin Pract 2006; 60: 160-6.
Rice HE, O’Keefe GE, Helton WS, et al. Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surg 1997; 132: 880-4.
Tsai MH, Chen YC, Ho YP, et al. Organ system failure scoring system can predict hospital mortality in critically ill cirrhotic patients. J Clin Gastroenterol 2003; 37: 251-7.
Zimmerman JE, Wagner DP, Seneff MG, et al. Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival. Hepatology 1996; 23: 1393-401.
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
Cholongıtas E, Senzolo M, Patch D, et al. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther 2006; 23: 883-93.
Huo TI, Wu JC, Lin HC, et al. Evaluation of the increase in model for end-stage liver disease (DMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatology 2005; 42: 826-32.
Papatheodoridis GV, Cholongitas E, Dimitriadou E, et al. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol 2005; 11: 3099-104.
Sumskiene J, Kupcinskas L, Pundzius J, et al. Prognostic factors for short and long-term survival in patients selected for liver transplantation. Medicina (Kaunas) 2005; 41: 39-46.
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease [Comment]. Hepatology 2001; 33: 464-70.
Yoo HY, Edwin D, Thuluvath PJ. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites. Am J Gastroenterol 2003; 98: 1395-9.
Huo TI, Lin HC, Wu JC, et al. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant 2006; 20: 188-94.
Singh N, Gayowski T, Wagener MM, et al. Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality. J Gastroenterol 1998; 33: 73-9.
Zauner CA, Apsner RC, Kranz A, et al. Outcome prediction for patients with cirrhosis of the liver in a medical ICU: a comparison of the APACHE scores and liver-specific scoring systems. Intensive Care Med 1996; 22: 559-63.
Arabi Y, Ahmed QA, Haddad S, et al. Outcome predictors of cirrhosis patients admitted to the intensive care unit. Eur J Gastroenterol Hepatol 2004; 16: 333-9.
Tsai MH, Peng YS, Lien JM, et al. Multiple organ system failure in critically ill cirrhotic patients. A comparison of two multiple organ dysfunction/failure scoring systems. Digestion 2004; 69: 190-200.